Journal article icon

Journal article

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Abstract:

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW), we analyzed risk factors for treatment failure, defined as sustaining two or more fractures while on AOM. GLOW is a prospective, observational cohort study of women aged ≥55 years sampled from primary care pract...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1002/jbmr.2023

Authors


Díez-Pérez, A More by this author
Adachi, JD More by this author
Anderson, FA More by this author
Expand authors...
Journal:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Volume:
29
Issue:
1
Pages:
260-267
Publication date:
2014-01-05
DOI:
EISSN:
1523-4681
ISSN:
0884-0431
URN:
uuid:720878f5-a933-49e1-8410-b016b2f75d0d
Source identifiers:
445504
Local pid:
pubs:445504

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP